Cerner Corporation (Nasdaq:CERN) hit a new 52-week high Monday as it is currently trading at $99.07, above its previous 52-week high of $98.89 with 174,782 shares traded as of 10:21 a.m. ET. Average volume has been 781,600 shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Cerner Corporation (Nasdaq: CERN) hit a new 52-week high Monday as it is currently trading at $99.07, above its previous 52-week high of $98.89 with 174,782 shares traded as of 10:21 a.m. ET. Average volume has been 781,600 shares over the past 30 days. Cerner has a market cap of $16.83 billion and is part of the technology sector and computer software & services industry. Shares are up 26.3% year to date as of the close of trading on Friday. Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers worldwide. The company has a P/E ratio of 41.3, above the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Cerner as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full Cerner Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..